ScienceDex / Researcher record
Nagarkatti, Mitzi
- University of South Carolina at Columbia · Pathology (NIH department code)
- Virginia Commonwealth University · Microbiology & Immunology (NIH department code)
From the FY2005 NIH awards this investigator leads as contact PI. The department is the award's.
FY2005 NIH rank #5,803
- Rising Star
- Sustained Excellence
- R01 Holder
- Long-Funded
NIH Funding · FY2005
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2001 | $145,000 | 1 | #23,975 |
| 2002 | $145,000 | 1 | #25,930 |
| 2003 | $554,500 | 2 | #9,497 |
| 2004 | $883,680 | 3 | #5,343 |
| 2005 | $856,383 | 6 | #5,803 |
| 2010 | $308,250 | 1 | #27,803 |
| 2011 | $305,168 | 1 | #25,801 |
| 2012 | $305,168 | 1 | #26,107 |
| 2013 | $299,064 | 1 | #25,498 |
| 2014 | $302,117 | 1 | #25,805 |
| 2018 | $2,037,552 | 1 | #2,756 |
| 2019 | $2,016,232 | 1 | #3,097 |
| 2020 | $1,994,479 | 1 | #939 |
| 2021 | $2,722,208 | 3 | #2,036 |
| 2022 | $2,446,901 | 2 | #2,533 |
| 2023 | $584,421 | 3 | #20,911 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20011 record
- FY20021 record
- FY20032 records
- FY20043 records
- FY2005 · selected6 records
- FY20101 record
- FY20111 record
- FY20121 record
- FY20131 record
- FY20141 record
- FY20181 record
- FY20191 record
- FY20201 record
- FY20213 records
- FY20222 records
- FY20233 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
- Microbiology & Immunology
FY2005 award records by amount
NIH award records listing Nagarkatti, Mitzi as a PI. Multi-PI records show the full award amount for context.
- 7R01AI058300-03R01Contact PICytotoxic lymphocytes in acute lung injuryUniversity of South Carolina at Columbia · Pathology (NIH department code)$226.4Kaward amount
- 7R01HL058641-08R01Contact PIEndothelial cell injury by cytolytic lymphocytesUniversity of South Carolina at Columbia · Pathology (NIH department code)$210.5Kaward amount
- 5R01AI053703-03R01Contact PIRole of CD44 in EC injury and melanoma therapyVirginia Commonwealth University · Microbiology & Immunology (NIH department code)$193.5Kaward amount
- 7R01AI053703-04R01Contact PIRole of CD44 in EC injury and melanoma therapyUniversity of South Carolina at Columbia · Pathology (NIH department code)$100.9Kaward amount
- 5R01AI058300-02R01Contact PICytotoxic lymphocytes in acute lung injuryVirginia Commonwealth University · Microbiology & Immunology (NIH department code)$81.9Kaward amount
- 5R01HL058641-07R01Contact PIEndothelial cell injury by cytolytic lymphocytesVirginia Commonwealth University · Microbiology & Immunology (NIH department code)$43.3Kaward amount
Award organizations
Organizations that administered FY2005 awards listing Nagarkatti, Mitzi as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardUniversity of South Carolina at Columbia
- 2002Multi-Institutional ResearchAwards at 2 institutions
- 2003$500K Cumulative Funding
- 2003Entered Top 50% NationallyRanked #9497
- 2004$1M Cumulative Funding
- 2005$2M Cumulative Funding
- 2010R01 Grant Holder
- 2018$5M Cumulative Funding
- 2018Entered Top 25% NationallyRanked #2756
- 2020$10M Cumulative Funding
- 2020Entered Top 10% NationallyRanked #939
- 2020Entered Top 5% NationallyRanked #939